| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.5 | $0-$5k | 0.00 |
Summary
A vulnerability has been found in Xerox FreeFlow Core up to 8.0.7 and classified as critical. Impacted is an unknown function. The manipulation leads to path traversal. This vulnerability is referenced as CVE-2026-2251. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability was found in Xerox FreeFlow Core up to 8.0.7. It has been rated as critical. This issue affects an unknown part. The manipulation with an unknown input leads to a path traversal vulnerability. Using CWE to declare the problem leads to CWE-22. The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
Improper limitation of a pathname to a restricted directory (Path Traversal) vulnerability in Xerox FreeFlow Core allows unauthorized path traversal leading to RCE. This issue affects Xerox FreeFlow Core versions up to and including 8.0.7. Please consider upgrading to FreeFlow Core version 8.1.0 via the software available on - https://www.support.xerox.com/en-us/product/core/downloads https://www.support.xerox.com/en-us/product/core/downloads
It is possible to read the advisory at securitydocs.business.xerox.com. The identification of this vulnerability is CVE-2026-2251 since 02/09/2026. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $0-$5k at the moment (estimation calculated on 02/27/2026). The attack technique deployed by this issue is T1006 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.xerox.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.5VulDB Meta Temp Score: 8.5
VulDB Base Score: 7.3
VulDB Temp Score: 7.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 9.8
CNA Vector (Xerox): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Path traversalCWE: CWE-22
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
02/09/2026 CVE reserved02/27/2026 Advisory disclosed
02/27/2026 VulDB entry created
02/27/2026 VulDB entry last update
Sources
Vendor: xerox.comAdvisory: securitydocs.business.xerox.com
Status: Confirmed
CVE: CVE-2026-2251 (🔒)
GCVE (CVE): GCVE-0-2026-2251
GCVE (VulDB): GCVE-100-348155
Entry
Created: 02/27/2026 09:41Changes: 02/27/2026 09:41 (61)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.